BioCentury
ARTICLE | Financial News

Bind sets IPO range

September 5, 2013 11:48 PM UTC

Bind Therapeutics Inc. (Cambridge, Mass.) amended its IPO and now plans to sell 4.7 million shares at $14-$16. At the $15 midpoint, the company would raise $70.1 million and be valued at $236.7 million. Credit Suisse; Cowen; Stifel; and JMP Securities are underwriters. Last month, Bind filed to raise up to $80.5 million in an IPO. ...